References
- Abringer, J. (2000) NuRD and SIN3: histone deacetylase complexes in development. Trends Genet. 16, 351-356. https://doi.org/10.1016/S0168-9525(00)02066-7
- Anand, L., Muhie, R., Hou Jr., H., Potes, J., Chin, L., Schreiber-Agus, N., and DePinho, R. A. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55. https://doi.org/10.1038/387049a0
- Bannister, A. J., and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643. https://doi.org/10.1038/384641a0
- Bannister, A. J., Miska, E., Gorlich, D., and Kouzarides, T. (2000) Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr. Biol. 10, 467-70. https://doi.org/10.1016/S0960-9822(00)00445-0
- Bernstein, B. E., Tong, J. K., and Schreiber, S. L. (2000) Genomewide studies of histone deacetylase function in yeast. Proc. Natl. Acad. Sci. USA 97, 13708-13713. https://doi.org/10.1073/pnas.250477697
- Butler, L. M., Higgins, B., Fox, W. D., Agus, D. B., Cordon- Cardo, C., and Scher, H. J. (2000) Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft. Proc. Am. Assoc. Cancer Res. 41, Abstract 2396.
- Carducci, M., Bowling, M. K, Eisenberger, M., Sinibaldi, V., Chen, T., and Nor, D. (1997) Phenylbutyrate (PB) for refractory solid tumors: Phase I clinical and pharmacologic evaluation of intravenous and oral PB. Anticancer Res. 17, 3972-3973.
- Chen, H., Lin, J. R., Xie, W., Wilpitz, D., and Evans, M. R. (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98, 675-686. https://doi.org/10.1016/S0092-8674(00)80054-9
- Choi, J. H., Kwon, H. J., Yoon, B. I., Kim, J. H., Han, S. U., Joo, H. J., and Kim, D. Y. (2001) Expression Profile of Histone Deacetylasel in Gastric Cancer Tissues. Jpn. J. Cancer Res. 92, 1300-1304. https://doi.org/10.1111/j.1349-7006.2001.tb02153.x
- Cohen, L. A., Amin, S., Marks, P. A., Rifkind, R. A., Desai, D., and Richon, V. M. (1999) Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). Anticancer Res. 19, 4999-5005.
- Cress, W. D., and Seto, E., (2000) Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184, 1-16. https://doi.org/10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7
- Davie, J. R. (l998) Covalent modifications of histones: expression from chromatin templates. Curr. Opin. Genet. Dev. 8, 173-178. https://doi.org/10.1016/S0959-437X(98)80138-X
- Deroanne, C. F., Bonjean, K, Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J. M., Nusgens, B. V., and Castronovo, V. (2002) Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 21, 427-436. https://doi.org/10.1038/sj.onc.1205108
- Dhordain, P., Lin, R. J., Quief, S., Lantoine, D., Kerckaert, J. P., Evans, R. M., and Albagli, O. (1998) The LAZ3 (BCL06) oncoprotein recruits a SMRT/Msin3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26, 4645-4651. https://doi.org/10.1093/nar/26.20.4645
- Finnin, M. S .. Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., and Pavletich, N. P. (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188-193. https://doi.org/10.1038/43710
- Folkman, J. (1996) Fighting cancer by attacking its blood supply. Sci. Am. 275, 150-154. https://doi.org/10.1038/scientificamerican0996-150
- Furumai, R., Matsuyama, A., Koba,hi, N., Lee, K. H., Nishiyama, M., Nakajima, H., Tanaka. A., Komatsu, Y., Nishino, N., Yoshida, M., and Horinouchi, S. (2002) FK228(depsipeptide) as a natural prodrug that inhibits class I histone deacetylase. Cancer Res. 62, 4916-4921.
- Galasinski, S. C., Resing, K. A, Goodrich, J. A., and Ahn, N. G. (2002) Phosphatase inhibition leads to histone deacetylase 1 and 2 phosphorylation and disruption of co-repressor interaction. J. BioI. Chem. 277. 19618-19626. https://doi.org/10.1074/jbc.M201174200
- Glick, R. D., Swendeman, S. L., Coffey, D. C., Ridkind, R. A., Marks, P. A., and Richon, V. M. (1999) Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res. 59, 4392-4399.
- Grozinger, C. M., Hassig, C. A, and Schreiber, S. L. (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 96, 4868- 4873. https://doi.org/10.1073/pnas.96.9.4868
- Grozinger, C. M., and Schreiber, S. L. (2000) Regulation of histone deacetylases 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97, 7835-7840. https://doi.org/10.1073/pnas.140199597
- Gu, W., and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606. https://doi.org/10.1016/S0092-8674(00)80521-8
- Guschin, D., Wade, P. A., Kikyo, N., and Wolffe, A. P. (2000) ATP-dependent histone octamer mobilization and histone deacetylation mediated by the Mi-2 chromatin remodeling complex. Biochemistry 39, 5238-5245. https://doi.org/10.1021/bi000421t
- Hassig, C. A, Fleischer, T. C., Billin, A. N., Schreiber, S. L., and Ayer, D. E. (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347. https://doi.org/10.1016/S0092-8674(00)80214-7
- Heizel, T., Lavinsky, R. M., Mullen, T., Soderstrome, M., Laherty, C. D., Torchia, J., Yang, W., Brard, G., Ngo, S. D., Davie, J. R., Seto, E., Eisenman, R. N., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48. https://doi.org/10.1038/387043a0
- Hoshikawa, Y., Kwon, H. J., Yoshida, M., Horinouchi, S., and Beppu, T. ( 1994) Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp. Cell Res. 214, 189-197. https://doi.org/10.1006/excr.1994.1248
- Huang, E. Y., Zhang, J., Miska, E. A., Guenther. M. G., Kouzarides, T., and Lazar, M. A. (2000) Nuclear receptor co-repressor partner with class II histone deacetylases in a Sin3- independent repression pathway. Genes Dev. 14, 45-54.
- Hubbert, C.. Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X. F., Yao, T. P. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458. https://doi.org/10.1038/417455a
- Hwang, H. S., Suh, N. Y and Song, K. W. (2000) The fission yeast Hda 1p functions on the regulation of proper cell division. J. Biochem. Mol. Biol. 33, 263-267.
- Imfor, A., Yang, X. J., Ogryzko, V. V., Nakatani, Y., Wolffe, A. P., and Ge, H. (1997) Acetylation of general transcription factors by histone acetyltransferase. Curr. BioI. 7, 689-692. https://doi.org/10.1016/S0960-9822(06)00296-X
- Kadosh, D., and Struhl, K. (1997) Repression by Ume6 involves recruitment of a complex containing Sin3 co-repressor and Rpd3 histone deacetylase to target promoters. Cell 89, 365-371. https://doi.org/10.1016/S0092-8674(00)80217-2
- Khochbin, S., and Kao, H. (2001) Histone deacetylase complexes: functional entities or molecular reservoirs. FEBS Lett. 494, 141-144. https://doi.org/10.1016/S0014-5793(01)02327-4
- Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., and Beppu, T. (1993) Trapoxin. an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268, 22429-22435.
- Kim, M. S., Kwon, H. J., Lee, Y. M., Baec, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K, Chung, H. Y, Kim, C. W., and Kim, G. W. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nature Med. 7,437-443. https://doi.org/10.1038/86507
- Kornberg, R. D. (1974) Chromatin structure: a repeating unit of histones and DNA. Science 184, 868-871. https://doi.org/10.1126/science.184.4139.868
- Kornberg, R. D., and Lorch, Y., (1999) Twenty-five years of the Nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-294. https://doi.org/10.1016/S0092-8674(00)81958-3
- Kouzarides, T. (1999) Histone acetylase and deacetylase in cell proliferation. Curr. Opin. Genet. Dev. 9, 40-48. https://doi.org/10.1016/S0959-437X(99)80006-9
- Kwon, H. J., Kim, M. S., Kim, M. J., Nakajiam, H., and Kim. K. W. (2002) Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int. J. Cancer 97, 290-296. https://doi.org/10.1002/ijc.1602
- Kwon, H. J., Kim, M. J., and Kim, S. Y. (2002) New Yeast Cell- Based Assay System for Screening of Histone Deacetylasel Complex Disruptor. J. Microbial. Biotech. 12, 286-291.
- Kwon, H. J., Owa, T., Hassig, C. A., Shimada, J., and Schreiber, S. L. (1998) Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 3356-3361. https://doi.org/10.1073/pnas.95.7.3356
- Laherty, C. D., Yang, W., Sun, J., Davie, J. R, Seto, E., and Eisenman, R. N. (1997) Histone deacetylases associated with the mSin3 co-repressor mediate Mad transcriptional repression. Cell 89, 349-356. https://doi.org/10.1016/S0092-8674(00)80215-9
- Lander, J., Sutton, A., Tafrov, S. T., Heller. R C., Stebbin, J., Pillus, L., and Sternglanz, R. (2000) The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. USA 97, 5807-5811. https://doi.org/10.1073/pnas.110148297
- Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M., and Khochbin, S. (2000) mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275, 15594-15599. https://doi.org/10.1074/jbc.M908437199
- Lim, Y., Han, I., Kwon, H. J., and Oh, E. S. (2002) Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts. J. Biol. Chem. 277, 12735-12740. https://doi.org/10.1074/jbc.M111011200
- Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997) Crystal structure of the Nucleosome core particle at 2.8A resolution. Nature 389, 251-260. https://doi.org/10.1038/38444
- Luo, R W., Postigo, A. A., and Dean, D. C. (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92, 463- 473. https://doi.org/10.1016/S0092-8674(00)80940-X
- Mahoney, M. G., Simpson, A., Jost, M., Noe, M., Kari, C., Pepe, D., Choi, Y. W., Uitto, J., and Rodeck, U. (2002) Metastasis-associated protein 1 (MTA1) enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 21, 2161-2170. https://doi.org/10.1038/sj.onc.1205277
- Marks, P. A., and Rifkind, R. A. (1978) Erythroleukemic differentiation. Annu. Rev. Biochem. 47, 419-448. https://doi.org/10.1146/annurev.bi.47.070178.002223
- Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R, Miller, T., and Kelly, W. K. (2001) Histone deacetylase and cancer: causes and therapies. Nature Rev. Cancer 1, 194-202. https://doi.org/10.1038/35106079
- Martinez-Balbas, M., Bauere, U. M., Nielsen, S. J., Brehm, A., and Kouzarides, T. (2000) Regulation of E2F activity by acetylation. EMBO J. 19,662-671. https://doi.org/10.1093/emboj/19.4.662
- Marzio, G., Wagenre, C., Gutierrez, M. I., Cartwright, P., Helin, K., and Giacca, M. (2000) E2F family members are differentially regulated by reverse acetylation. J. Biol. Chem. 275, 10887-10892. https://doi.org/10.1074/jbc.275.15.10887
- Mazumdar, A., Wang, R., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandai, M., Vadlamudi, R. K, and Kumar, R., (2001) Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 co-repressor. Nature Cell BioI. 3, 30-37. https://doi.org/10.1038/35050532
- Mizzen, C. A., Yang, X. J., Kokubo, T., Brownell, J. E., Bannister, A. J., and Owen-Hughes, T. (1996) The TAF (II) 250 subunit of TF(II)D has histone acetyltransferase activity. Cell 87, 1261-1270. https://doi.org/10.1016/S0092-8674(00)81821-8
- Munshi, N., Merika, M., Yie, J., Senger, K., Chen. G., and Thanos, D. (1998) Acetylation of HMG1 (Y) by CBP turns off IFNB expression by disrupting the enhanceosome. Mol. Cell 2, 457-467.
- Nagy, L., Kao, H., Chakravarti, D., Lin, R., Hassg, C. A., Ayer, D. E., Schreiber, S. L., and Evans, R. M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase. Cell 89, 373-380. https://doi.org/10.1016/S0092-8674(00)80218-4
- Nan, X, Ng, H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N. and Bird, A. (1998) Transcriptional repression by the methl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389. https://doi.org/10.1038/30764
- Newmark, H. L., Lupton, J. R. and Young, C. W. (1994) Butyrate as a differentiating agent; pharmacokinetics, analogues and current status. Cancer Lett. 78, 1-5. https://doi.org/10.1016/0304-3835(94)90023-X
- Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. and Nakatino, Y. (1996) The transcriptional co-activators p300 and CBP are histone acetyltransferase. Cell 87, 953-959. https://doi.org/10.1016/S0092-8674(00)82001-2
- Pandolfi, P. P. (2001) Transcription therapy for cancer. Oncogene 20, 3116-3127. https://doi.org/10.1038/sj.onc.1204299
- Pflum, M. K, Tong, J. K. Lane, W. S., and Schreiber, S. L. (2001) Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J. Biol. Chem. 276, 47733-47741. https://doi.org/10.1074/jbc.M105590200
- Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R C., Masuno, M., Tommerup, N., van Ommen, G. J., Goodman, R. H., and Peters, D. J. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351. https://doi.org/10.1038/376348a0
- Prakash, S., Foster. B. J., Meyer, M., Wozniak, A, Heibrum, L. K, Flaherty, L., Zalupski, M., Radulovic, L., Valdivieso, M., and LoRusso. P. M. (2001) Chronic oral administration of CI-994: a Phase I study. Investg. New Drugs 19, 1-11. https://doi.org/10.1023/A:1006489328324
- Qui, L., Kelso, M. J., Hansen, C., West, M. L., Fairlie, D. P., and Parsons, P. G. (1999) Anti-tumor activity in vitro and in vivo of selective differentiating agnets containing hydroxamate. Br. J. Cancer 80, 1252.1258. https://doi.org/10.1038/sj.bjc.6690493
- Richon. V. M., Emiliani, S., Verdin, E., Webb, Y, Breslow, R, and Rifkind, R. A. (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 3003-3007. https://doi.org/10.1073/pnas.95.6.3003
- Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., and Ando. T. (1999) A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96, 4592-4597. https://doi.org/10.1073/pnas.96.8.4592
- Spencer, T. E., Jenster. G., Burcin, M. M., Allis, C. D., Zhou, J., and Mizzen, C. A. (1997) Steroid receptor co-activator-1 is a histone acetyltransferase. Nature 389, 194-198. https://doi.org/10.1038/38304
- Sterner, R., Vidali, G., and All frey, V. G. (1979) Studies of acetylation and deacetylation in high mobility group proteins. Identification of the sites of acetylation in HMG-1. J. BioI. Chem. 254. 11577-11583.
- Sternson. S. M., Wong, J. C., Grozinger, C. M., and Schreiber, S. L. (2001) Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org. Lett. 3, 4239-4242. https://doi.org/10.1021/ol016915f
- Struhl, K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606. https://doi.org/10.1101/gad.12.5.599
- Sugita, K., Yoshida, H., Matsumoto, M., and Matsutani, S. (1992) A novel compound. depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. Biochem. Biophys. Res. Commun. 182, 379-387. https://doi.org/10.1016/S0006-291X(05)80156-1
- Takemura, R., Okabe, S., Vmeyama, T., Kanai, Y., Cowan, N. J., and Hirokawa, N. (1992) Increased microtubule stability and a-tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J. Cell Sci. 103, 953-964.
- Taunton, J., Hassig, C. A., and Schreiber, S. L. (1996) A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411. https://doi.org/10.1126/science.272.5260.408
- Toh, Y., Pencil, S. D., and Nicolson, G. L., (1998) A novel candidate metastasis-associated gene, mta1. differentially expressed in highly metastatic mammary adenocarcinoma cell lines. J. BioI. Chem. 269, 22958-22963.
- Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., and Schreiber, S. L. (1998) Chromatin deacetylation by an ATP-dependent nucleosome remodeling complex. Nature 395, 917-921. https://doi.org/10.1038/27699
- Tsuji, N., Kobaysshi, M., Nagashima, K, Wakisaka, Y., and Koizumi, K. (1976) A new antifungal antibiotics, trichostatin. J. Antibiot. (Tokyo). 29, 1-6. https://doi.org/10.7164/antibiotics.29.1
- Ueda, H., Nakajima, H., Hori, Y., Goto, T., and Okuhara, M. (1994) Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. Biosci. Biotechnol. Biochem. 58, 1579-1583. https://doi.org/10.1271/bbb.58.1579
- Van Lint, C., Emiliani, S., and Verdin, E. (1996) The expression of a small fraction of cellular gene is changed in response to histone hyperacetylation. Gene Expr. 5, 245-254.
- Wittich, S., Scherf, H., Xie, C., Brosch, G., Loidl, P., Gerhauser, C., and Jung, M. (2002) Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. J. Med. Chem. 45, 3296-3309. https://doi.org/10.1021/jm0208119
- Yang, W., Inouye, C., Zeng, Y., Bearss, D., and Seto, E. (1996) Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93, 12845-12850. https://doi.org/10.1073/pnas.93.23.12845
- Yoshida, M., Horinouchi, S., and Beppu, T. (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423-430. https://doi.org/10.1002/bies.950170510
- Yoshida, M., Kijima, M., Akita, M., and Beppu, T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174-17179.
- Zhang, W., and Bieker, J. J. (1998) Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferase. Proc. Natl. Acad. Sci. USA 95, 9855-9860. https://doi.org/10.1073/pnas.95.17.9855
- Zhang. Y., Ng, H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylases core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935. https://doi.org/10.1101/gad.13.15.1924
Cited by
- Hipertrofia cardiaca: eventos moleculares y celulares vol.59, pp.5, 2006, https://doi.org/10.1157/13087900
- HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells vol.324, pp.1, 2004, https://doi.org/10.1016/j.bbrc.2004.09.016
- Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity vol.1822, pp.5, 2012, https://doi.org/10.1016/j.bbadis.2011.11.002
- Epigenetic Regulation by Dietary Phytochemicals in Photocarcinogenesis vol.1, pp.1, 2015, https://doi.org/10.1007/s40495-015-0021-2
- Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21waf1 vol.298, pp.2, 2004, https://doi.org/10.1016/j.yexcr.2004.04.038
- Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease vol.690, pp.1-2, 2010, https://doi.org/10.1016/j.mrfmmm.2010.02.006
- Global histone profiling by LC–FTMS after inhibition and knockdown of deacetylases in human cells vol.877, pp.30, 2009, https://doi.org/10.1016/j.jchromb.2009.09.042
- Histone deacetylase inhibitor FK228 suppresses the Ras–MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma 2005, https://doi.org/10.1038/sj.onc.1209072
- The ergot alkaloid gene cluster: Functional analyses and evolutionary aspects vol.70, pp.15-16, 2009, https://doi.org/10.1016/j.phytochem.2009.05.023
- BimEL-dependent apoptosis induced in peripheral blood lymphocytes withn-butyric acid is moderated by variation in expression of c-myc and p21(WAF1) vol.26, pp.4, 2008, https://doi.org/10.1002/cbf.1474
- Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates vol.54, pp.1, 2004, https://doi.org/10.1007/s00280-004-0766-5
- Cardiac Hypertrophy: Molecular and Cellular Events vol.59, pp.5, 2006, https://doi.org/10.1016/S1885-5857(06)60796-2
- Epstein-Barr Virus-infected Akata Cells Are Sensitive to Histone Deacetylase Inhibitor TSA-provoked Apoptosis vol.38, pp.6, 2005, https://doi.org/10.5483/BMBRep.2005.38.6.755
- Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin vol.127, pp.6, 2010, https://doi.org/10.1002/ijc.25151
- In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC) vol.12, pp.Suppl 13, 2011, https://doi.org/10.1186/1471-2105-12-S13-S23
- Effect of histone deacetylase inhibitor sodium butyrate on viability and life span in Drosophila melanogaster vol.3, pp.1, 2013, https://doi.org/10.1134/S2079057013010153
- Chromatin-remodelling mechanisms in cancer vol.658, pp.3, 2008, https://doi.org/10.1016/j.mrrev.2008.01.008
- Repetitive Treatments of Colon HT-29 Cells with Diallyl Disulfide Induce a Prolonged Hyperacetylation of Histone H3 K14 vol.1030, pp.1, 2004, https://doi.org/10.1196/annals.1329.071
- Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome vol.94, pp.2, 2006, https://doi.org/10.1038/sj.bjc.6602939
- MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases vol.4, pp.2, 2011, https://doi.org/10.1007/s12307-011-0062-y
- SAHA Inhibits the Growth of Colon Tumors by Decreasing Histone Deacetylase and the Expression of Cyclin D1 and Survivin vol.18, pp.3, 2012, https://doi.org/10.1007/s12253-012-9499-7
- Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia vol.5, pp.5, 2013, https://doi.org/10.2217/epi.13.56
- Selective transcription and cellular proliferation induced by PDGF require histone deacetylase activity vol.343, pp.2, 2006, https://doi.org/10.1016/j.bbrc.2006.03.013
- Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers vol.20, pp.7, 2005, https://doi.org/10.1111/j.1440-1746.2005.03807.x
- Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase vol.94, pp.2, 2005, https://doi.org/10.1016/j.actatropica.2005.03.004
- Synthesis of ω-Oxo Amino Acids andtrans-5-Substituted Proline Derivatives Using Cross-Metathesis of Unsaturated Amino Acids vol.81, pp.18, 2016, https://doi.org/10.1021/acs.joc.6b01571
- Effect of Broccoli Intake on Markers Related to Oxidative Stress and Cancer Risk in Healthy Smokers and Nonsmokers vol.61, pp.2, 2009, https://doi.org/10.1080/01635580802425688
- Metabolism as a key to histone deacetylase inhibition vol.46, pp.3, 2011, https://doi.org/10.3109/10409238.2011.557713
- Connectedness of PPI network neighborhoods identifies regulatory hub proteins vol.27, pp.8, 2011, https://doi.org/10.1093/bioinformatics/btr099
- Epigenetic Alterations in Ultraviolet Radiation-Induced Skin Carcinogenesis: Interaction of Bioactive Dietary Components on Epigenetic Targets† vol.88, pp.5, 2012, https://doi.org/10.1111/j.1751-1097.2011.01020.x
- Regulation at multiple levels of NF-κB-mediated transactivation by protein acetylation vol.68, pp.6, 2004, https://doi.org/10.1016/j.bcp.2004.05.039
- APE1/Ref-1 regulates PTEN expression mediated by Egr-1 vol.42, pp.1, 2008, https://doi.org/10.1080/10715760701765616
- Novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction in oral squamous cell carcinoma vol.02, pp.03, 2011, https://doi.org/10.4236/jbpc.2011.23026
- The Role of Small Molecule Inhibitors for Veterinary Patients vol.37, pp.6, 2007, https://doi.org/10.1016/j.cvsm.2007.06.003
- Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma vol.116, pp.3, 2010, https://doi.org/10.1182/blood-2009-07-235663
- research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia vol.150, pp.6, 2010, https://doi.org/10.1111/j.1365-2141.2010.08301.x
- Sulforaphane (SFN): An Isothiocyanate in a Cancer Chemoprevention Paradigm vol.2, pp.3, 2015, https://doi.org/10.3390/medicines2030141
- Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors vol.116, pp.5, 2005, https://doi.org/10.1002/ijc.21069
- Epigenetic targets of bioactive dietary components for cancer prevention and therapy vol.1, pp.3-4, 2010, https://doi.org/10.1007/s13148-010-0011-5
- Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates vol.62, pp.3, 2008, https://doi.org/10.1007/s00280-007-0622-5
- Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells vol.225, pp.2, 2010, https://doi.org/10.1002/jcp.22236
- Processing of DNA double strand breaks by alternative non-homologous end-joining in hyperacetylated chromatin vol.3, pp.1, 2012, https://doi.org/10.1186/2041-9414-3-4
- Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy vol.28, pp.5, 2008, https://doi.org/10.1002/med.20120
- Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma vol.49, pp.2, 2005, https://doi.org/10.1016/j.lungcan.2005.02.006
- A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer vol.69, pp.3, 2012, https://doi.org/10.1007/s00280-011-1762-1
- T Cell Tolerance Induced by Histone Deacetylase Inhibitor is Mediated by P21cip1 vol.27, pp.4, 2005, https://doi.org/10.1080/08923970500416749
- Synthesis of a novel series of benzylether-containing cinnamoyl derivatives as histone deacetylase inhibitors vol.25, pp.1, 2010, https://doi.org/10.3109/14756360903049034
- Apoptotic and autophagic cell death induced by histone deacetylase inhibitors vol.101, pp.52, 2004, https://doi.org/10.1073/pnas.0408345102
- Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis vol.415, pp.1-2, 2016, https://doi.org/10.1007/s11010-016-2690-5
- Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells vol.50, pp.3, 2009, https://doi.org/10.1002/em.20447
- Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases vol.33, pp.2, 2012, https://doi.org/10.1093/carcin/bgr277
- Differential Effects of Histone Deacetylase Inhibitors in Tumor and Normal Cells—What Is the Toxicological Relevance? vol.35, pp.4, 2005, https://doi.org/10.1080/10408440590935639
- The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer vol.4, 2014, https://doi.org/10.3389/fonc.2014.00111